Literature DB >> 18330656

Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis.

Neus Franco-Pons1, Judit Marsillach, Jorge Joven, Jordi Camps, Daniel Closa.   

Abstract

Oxidative stress has a primary role in the pathogenesis of severe acute pancreatitis. Then, the antioxidant capacity is a critical factor in the progression of this disease. Serum paraoxonase-1 (PON1) is an esterase associated with high-density lipoprotein, which clinical interest resides in its ability to prevent or limit the lipid oxidation. The aim of this study was to investigate changes in PON1 activity in the early stages of acute pancreatitis and to find out if its alteration is related with the severity of the disease. To this purpose, we used an experimental model of taurocholate-induced mild and severe acute pancreatitis. Our results showed that serum activity and PON1 concentration decreased 18 h after the induction of a severe acute pancreatitis. In vitro analysis revealed that incubation with oxidized lipids obtained from pancreatitis samples results in the inactivation of the enzyme in a concentration-dependent manner. In addition to oxidative inactivation, we observed by Western blot, an immunoreactive band suggestive of proteolytic degradation of the enzyme, altogether indicating that during severe acute pancreatitis, there is a significant decrease in serum PON1 activity. This decrease is related with inactivation of the enzyme by oxidized lipids, probably followed by proteolytic degradation of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18330656     DOI: 10.1007/s11605-008-0502-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  41 in total

1.  Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity and lipid profile in experimental acute pancreatitis.

Authors:  Ethem Unal; Hafize Uzun; Ramazan Kusaslan; Mustafa Dogan; Habibe Genc; Pembegul Gunes; Izzet Titiz
Journal:  Pancreas       Date:  2005-07       Impact factor: 3.327

2.  Concentration of free fatty acids in pancreatitis-associated ascitic fluid.

Authors:  T N Pappas; V C Gavino; E C Ellison; D G Cornwell; W G Pace; L C Carey
Journal:  Clin Chem       Date:  1981-02       Impact factor: 8.327

3.  Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage?

Authors:  B Rau; B Poch; F Gansauge; A Bauer; A K Nüssler; T Nevalainen; M H Schoenberg; H G Beger
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

4.  The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation.

Authors:  B Poch; F Gansauge; B Rau; U Wittel; S Gansauge; A K Nüssler; M Schoenberg; H G Beger
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

5.  Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.

Authors:  Su Duy Nguyen; Dai-Eun Sok
Journal:  Free Radic Res       Date:  2004-09

Review 6.  Oxygen free radicals and the systemic inflammatory response.

Authors:  Daniel Closa; Emma Folch-Puy
Journal:  IUBMB Life       Date:  2004-04       Impact factor: 3.885

Review 7.  Apoptosis versus necrosis in acute pancreatitis.

Authors:  Madhav Bhatia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02       Impact factor: 4.052

8.  Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids.

Authors:  H C Jha; G von Recklinghausen; F Zilliken
Journal:  Biochem Pharmacol       Date:  1985-05-01       Impact factor: 5.858

9.  Myeloperoxidase as a biomarker of skin irritation and inflammation.

Authors:  M A Trush; P A Egner; T W Kensler
Journal:  Food Chem Toxicol       Date:  1994-02       Impact factor: 6.023

Review 10.  Oxidative stress in acute and chronic pancreatitis.

Authors:  M H Schoenberg; D Birk; H G Beger
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

View more
  8 in total

Review 1.  Pharmacologically directed cell disposal: labeling damaged cells for phagocytosis as a strategy against acute pancreatitis.

Authors:  Michael Chvanov; Ole H Petersen; Alexei V Tepikin
Journal:  Mol Interv       Date:  2010-04

2.  Regulation of paraoxonase 1 (PON1) in PCB 126-exposed male Sprague Dawley rats.

Authors:  Hua Shen; Larry W Robertson; Gabriele Ludewig
Journal:  Toxicol Lett       Date:  2012-01-12       Impact factor: 4.372

3.  Regulation of hepatic paraoxonase-1 expression.

Authors:  Bianca Fuhrman
Journal:  J Lipids       Date:  2012-04-03

4.  Serum biomarkers of oxidative stress in cats with feline infectious peritonitis.

Authors:  F Tecles; M Caldín; A Tvarijonaviciute; D Escribano; S Martínez-Subiela; J J Cerón
Journal:  Res Vet Sci       Date:  2015-02-16       Impact factor: 2.534

Review 5.  Role of antioxidants and oxidative stress in the evolution of acute pancreatitis (Review).

Authors:  Vlad Pădureanu; Dan Nicolae Florescu; Rodica Pădureanu; Alice Elena Ghenea; Dan Ionuț Gheonea; Carmen Nicoleta Oancea
Journal:  Exp Ther Med       Date:  2022-01-05       Impact factor: 2.447

6.  Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis.

Authors:  Suzana Bojic; Jelena Kotur-Stevuljevic; Nevena Kalezic; Zorana Jelic-Ivanovic; Aleksandra Stefanovic; Ivan Palibrk; Lidija Memon; Zdravko Kalaba; Marina Stojanovic; Sanja Simic-Ogrizovic
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

Review 7.  Serum paraoxonase 1 (PON1) measurement: an update.

Authors:  Jose J Ceron; Fernando Tecles; Asta Tvarijonaviciute
Journal:  BMC Vet Res       Date:  2014-03-25       Impact factor: 2.741

Review 8.  The Role of PON1 Variants in Disease Susceptibility in a Turkish Population.

Authors:  Mahmoud Abudayyak; Tuğçe Boran; Rumeysa Tukel; Ezgi Oztas; Gül Özhan
Journal:  Glob Med Genet       Date:  2020-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.